Physician profile
James Towry
NPI 1952367716
$1,792.77
in general payments reported to CMS, 2019-2025
18 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $211 · 2021: $182 · 2022: $156 · 2023: $190 · 2024: $368 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $362.60 | 2019-2025 | Skyrizi |
| Regeneron Healthcare Solutions, INC. | $228.95 | 2019-2025 | Dupixent, Libtayo |
| Amgen INC. | $195.46 | 2020-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $185.08 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $176.42 | 2023-2025 | Sotyktu |
| Celgene Corporation | $154.99 | 2019 | |
| Genzyme Corporation | $89.12 | 2021-2022 | |
| Janssen Biotech, INC. | $75.30 | 2020-2021 | |
| Lilly USA, LLC | $63.80 | 2020-2024 | Ebglyss |
| Galderma Laboratories, L.P. | $56.28 | 2024-2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.52 | 2024 | Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.73 | 2019 | |
| Organon LLC | $30.12 | 2025 | Vtama |
| Leo Pharma INC. | $22.81 | 2025 | Anzupgo |
| Pfizer INC. | $17.47 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17.03 | 2019 | |
| Strata Skin Sciences, INC. | $13.86 | 2022 | |
| Sun Pharmaceutical Industries INC. | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Towry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.